Department of Pediatrics, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Department of Pediatrics, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Exp Mol Pathol. 2018 Feb;104(1):12-18. doi: 10.1016/j.yexmp.2017.11.017. Epub 2017 Dec 12.
It is accepted that alteration of connexin43 (Cx43) expression in glomeruli is a common pathological response in several forms of kidney diseases. To date, however the change of the Cx43 expression in obesity-related glomerulopathy (ORG) has not been reported. In this study, the alteration of Cx43 expression in the glomeruli of rat with ORG was defined. Five-week-old rats were fed with high-fat diet for 18weeks to establish the ORG model, then the histological change of glomeruli, the foot process effacement of podocyte, the markers for podocyte injury (nephrin,podocin and WT1) and Cx43 expression in glomeruli were examined respectively. The results demonstrated metabolic disorder, hyperinsulinemia, systemic inflammation and microalbuminuria in ORG rats. There was significant hypertrophy, glomerular expansion and inflammatory cell infiltration in the kidney of ORG rats compared to the control group. Significant foot process effacement of the podocyte in the glomeruli, nephrin loss and density reduction were shown in the ORG rats, and Cx43 expression was significant upregulated in glomeruli of ORG rats compared to the control group. The results indicate the correlation of overexpressed Cx43 with the obesity related renal inflammation and suggest that Cx43 might be a potential target in the development of obesity related glomerulopathy.
已有研究证实,连接蛋白 43(Cx43)在肾小球中的表达改变是多种肾脏疾病的常见病理反应。然而,到目前为止,肥胖相关性肾小球病(ORG)中 Cx43 表达的变化尚未见报道。本研究旨在明确 ORG 大鼠肾小球中 Cx43 表达的改变。5 周龄大鼠给予高脂饮食 18 周建立 ORG 模型,然后分别检测肾小球的组织学变化、足细胞足突融合、足细胞损伤标志物(nephrin、podocin 和 WT1)和 Cx43 在肾小球中的表达。结果表明,ORG 大鼠存在代谢紊乱、高胰岛素血症、全身炎症和微量白蛋白尿。与对照组相比,ORG 大鼠的肾脏出现明显肥大、肾小球扩张和炎性细胞浸润。ORG 大鼠肾小球足细胞的足突融合显著,nephrin 丢失和密度降低,Cx43 在肾小球中的表达显著上调。这些结果表明,Cx43 的过度表达与肥胖相关的肾脏炎症有关,并提示 Cx43 可能是肥胖相关性肾小球病发展的一个潜在靶点。